On the other hand, microglial osteopontin (SPP1), promotes remyelination in multiple sclerosis and is neuroprotective near infarcts in stroke but in Alzheimer’s disease it is part of the “disease-associated microglia” signature68. Here, SPP1 is linked to stroke disorder.